The Perspective of a Pharmacoeconomic Study: Targeting for Audiences

ISSN： 1043-6618

Source： Pharmacological Research, Vol.35, Iss.5, 1997-05, pp. : 471-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Clinical and Pharmacoeconomic Justification for Intravenous Acetylcysteine: A US Perspective

By Culley Colleen M.

Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol. 24, Iss. 2, 2005-01 ,pp. : 131-143

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Assessment of Olanzapine in the Treatment of Refractory Schizophrenia Based on a Pilot Clinical Study

By Sacristán J.A.

Clinical Drug Investigation, Vol. 15, Iss. 1, 1998-01 ,pp. : 29-35

Adis International

Access to resources Recommend Favorite

Patient Self-Reports in Pharmacoeconomic Studies: Their Use and Impact on Study Validity

By Evans C. Crawford B.

PharmacoEconomics, Vol. 15, Iss. 3, 1999-03 ,pp. : 241-256

Adis International

Access to resources Recommend Favorite

Targeting Cancer with Epi-Drugs: A Precision Medicine Perspective

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 10, 2016-08 ,pp. : 856-865

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacoeconomic research

By Postma Maarten J.

Pharmacy World and Science, Vol. 25, Iss. 6, 2003-12 ,pp. : 245-246

Springer Publishing Company

Access to resources Recommend Favorite